Product Code: GVR-4-68039-552-8
Veterinary Dermatology Drugs Market Growth & Trends:
The global veterinary dermatology drugs market is expected to reach USD 28.69 billion by 2030, registering a CAGR of 8.89% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market is driven by increasing pet expenditure, humanization of pets, robust R&D pipeline, launch of new products, the prevalence of dermatologic conditions, and initiatives by key companies. For example, in June 2023, Zoetis received FDA clearance for Apoquel Chewable- the country's first and only chewable pharmaceutical for controlling allergic itch and inflammation in dogs. This expanded the company's portfolio and supported its growth objectives.
The COVID-19 pandemic and macroeconomic headwinds from 2020 to 2022 had both positive and negative impacts on the market. This included operational challenges, supply chain disruption, limited access to veterinary care, spike in pet adoption, adoption of telemedicine, and increased penetration of pet insurance. Vimian for instance, reported dampened growth during Q1 2022 in its dermatology & specialty care segments due to volatility in shipments between quarters. By Q3 2022, the company reported robust growth in Dermatology & Specialty Care segments. Zoetis on the other hand witnessed volume growth of 14%, 3%, and 9% from in-line portfolio, including its dermatology products during Q2, Q3, and Q4 2021 respectively. In 2022, however, Zoetis reported 1-2% volume growth in its dermatology portfolio every quarter.
Ongoing research and development efforts in the field of veterinary dermatology have led to the creation of more effective and user-friendly drug formulations. These formulations are often easier to administer and can provide quicker relief for pets, ensuring medication compliance. Growing initiatives by key market players is expected to propel the R&D pipeline and promote the launch of new products in the market. In May 2023, Dechra Pharmaceuticals PLC for example, partnered with ILC Therapeutics in Scotland to research and develop the latter's Caniferon product for the treatment of atopic dermatitis in dogs. This added to the company's product pipeline.
Veterinary Dermatology Drugs Market Report Highlights:
- By indication, the parasitic infections segment dominated the market and held the largest revenue share of more than 40.0% in 2022 owing to increasing strategic initiatives by key companies
- For instance, Virbac expanded its medicinal product line by purchasing the rights to a number of early-stage parasiticides from Elanco in March 2021
- The allergic infections segment is anticipated to witness the fastest CAGR of over 9.2% during the forecast period
- The prescription segment dominated the market in 2022, whereas, the OTC segment is anticipated to grow at the fastest CAGR of about 9.1% from 2023 to 2030
- The companion animals dominated the market in 2022, due to the rise in pet ownership, public awareness, and demand for high-quality animal care
- The topical segment dominated the market in 2022 is expected to witness lucrative CAGR during the forecast period
- By distribution channel, hospital pharmacies dominated the market with a revenue share of 62.0% in 2022
- North America held the highest revenue share of over 38.0% of the market in 2022
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Veterinary Dermatology Drugs Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Pet Ownership
- 3.2.1.2. Growing Number Of Clinical Trials Related To Veterinary Dermatology Drugs
- 3.2.1.3. Rising Incidence Rate Of Parasitic As Well As Other Skin Diseases In Animals
- 3.2.1.4. Investments By Market Players
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Lack Of Awareness In Developing Regions
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Veterinary Dermatology Drugs Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.3. Pricing Analysis
- 3.3.4. Clinical Trial Analysis
- 3.3.5. Estimated Animal Population, by key countries, 2018 to 2022
- 3.3.6. COVID-19 Impact Analysis
Chapter 4. Veterinary Dermatology Drugs Market: Indication Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Veterinary Dermatology Drugs Market: Indication Movement Analysis & Market Share, 2022 & 2030
- 4.3. Parasitic Infections
- 4.3.1. Parasitic Infections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4. Allergic Infections
- 4.4.1. Allergic Infections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Others
- 4.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Veterinary Dermatology Drugs Market: Type Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Veterinary Dermatology Drugs Market: Type Movement Analysis & Market Share, 2022 & 2030
- 5.3. Prescription
- 5.3.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.4. OTC
- 5.4.1. OTC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Veterinary Dermatology Drugs Market: Animal type Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Veterinary Dermatology Drugs Market: Animal type Movement Analysis & Market Share, 2022 & 2030
- 6.3. Companion Animals
- 6.3.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2.1. Dogs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3.1. Cats Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. Horses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4.1. Horses Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4. Livestock Animals
- 6.4.1. Livestock Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Veterinary Dermatology Drugs Market: Route of Administration Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Veterinary Dermatology Drugs Market: Route of Administration Movement Analysis & Market Share, 2022 & 2030
- 7.3. Topical
- 7.3.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4. Oral
- 7.4.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5. Injectable
- 7.5.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Veterinary Dermatology Drugs Market: Distribution Channel Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Veterinary Dermatology Drugs Market: Distribution Channel Movement Analysis & Market Share, 2022 & 2030
- 8.3. Hospital Pharmacies
- 8.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.4. Retail
- 8.4.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.5. E-Commerce
- 8.5.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Veterinary Dermatology Drugs Market: Regional Estimates & Trend Analysis
- 9.1. Regional Outlook
- 9.2. Veterinary Dermatology Drugs Market: Regional Movement Analysis & Market Share, 2022 & 2030
- 9.3. North America
- 9.3.1. North America Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.2. U.S.
- 9.3.2.1. Key Country Dynamics
- 9.3.2.2. Regulatory Framework
- 9.3.2.3. U.S. Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.3.3. Canada
- 9.3.3.1. Key Country Dynamics
- 9.3.3.2. Regulatory Framework
- 9.3.3.3. Canada Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4. Europe
- 9.4.1. Europe Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. UK
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Regulatory Framework
- 9.4.2.3. UK Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Germany
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Regulatory Framework
- 9.4.3.3. Germany Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. France
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Regulatory Framework
- 9.4.4.3. France Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.5. Italy
- 9.4.5.1. Key Country Dynamics
- 9.4.5.2. Regulatory Framework
- 9.4.5.3. Italy Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.6. Spain
- 9.4.6.1. Key Country Dynamics
- 9.4.6.2. Regulatory Framework
- 9.4.6.3. Spain Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.7. Denmark
- 9.4.7.1. Key Country Dynamics
- 9.4.7.2. Regulatory Framework
- 9.4.7.3. Denmark Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.8. Sweden
- 9.4.8.1. Key Country Dynamics
- 9.4.8.2. Regulatory Framework
- 9.4.8.3. Sweden Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.9. Norway
- 9.4.9.1. Key Country Dynamics
- 9.4.9.2. Regulatory Framework
- 9.4.9.3. Norway Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5. Asia Pacific
- 9.5.1. Asia Pacific Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. Japan
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Regulatory Framework
- 9.5.2.3. Japan Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. China
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Regulatory Framework
- 9.5.3.3. China Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. India
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. Regulatory Framework
- 9.5.4.3. India Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. South Korea
- 9.5.5.1. Key Country Dynamics
- 9.5.5.2. Regulatory Framework
- 9.5.5.3. South Korea Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Australia
- 9.5.6.1. Key Country Dynamics
- 9.5.6.2. Regulatory Framework
- 9.5.6.3. Australia Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. Thailand
- 9.5.7.1. Key Country Dynamics
- 9.5.7.2. Thailand Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6. Latin America
- 9.6.1. Latin America Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. Brazil
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Regulatory Framework
- 9.6.2.3. Brazil Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. Mexico
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Regulatory Framework
- 9.6.3.3. Mexico Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.4. Argentina
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Regulatory Framework
- 9.6.4.3. Argentina Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7. Middle East & Africa
- 9.7.1. Middle East & Africa Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.2. South Africa
- 9.7.2.1. Key Country Dynamics
- 9.7.2.2. Regulatory Framework
- 9.7.2.3. South Africa Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.3. Saudi Arabia
- 9.7.3.1. Key Country Dynamics
- 9.7.3.2. Regulatory Framework
- 9.7.3.3. Saudi Arabia Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.4. UAE
- 9.7.4.1. Key Country Dynamics
- 9.7.4.2. Regulatory Framework
- 9.7.4.3. UAE Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.5. Kuwait
- 9.7.5.1. Key Country Dynamics
- 9.7.5.2. Regulatory Framework
- 9.7.5.3. Kuwait Veterinary Dermatology Drugs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Key Company Profiles
- 10.1.1. Participant's Overview
- 10.1.2. Indication Benchmarking
- 10.1.3. Financial Performance
- 10.1.4. Strategic Initiatives
- 10.1.4.1. Elanco
- 10.1.4.2. Ceva
- 10.1.4.3. Vetoquinol
- 10.1.4.4. Merck & Co., Inc.
- 10.1.4.5. Zoetis
- 10.1.4.6. Virbac
- 10.1.4.7. Bimeda, Inc
- 10.1.4.8. Vivaldis
- 10.1.4.9. Bioiberica S.A.U.
- 10.1.4.10. Boehringer Ingelheim International GmbH
- 10.2. Participant Categorization
- 10.3. Heat Map Analysis/ Company Market Position Analysis
- 10.4. Strategy Mapping
- 10.5. List of Other Key Market Players